• 30 Citations
  • 3 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hui-Huang Lai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
oxaliplatin Medicine & Life Sciences
Vascular Endothelial Growth Factor Receptor-3 Medicine & Life Sciences
Proteolysis Medicine & Life Sciences
RNA-Binding Proteins Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Response Elements Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Colonic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2019

  • 30 Citations
  • 3 h-Index
  • 5 Article
2 Citations (Scopus)

TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

Lai, H. H., Li, C. W., Hong, C. C., Sun, H. Y., Chiu, C. F., Ou, D. L. & Chen, P. S., 2019 Apr, In : Molecular Oncology. 13, 4, p. 928-945 18 p.

Research output: Contribution to journalArticle

Open Access
RNA-Binding Proteins
Response Elements
Transcriptional Activation
Hepatocellular Carcinoma
Neoplastic Stem Cells
7 Citations (Scopus)

HIF-1α promotes autophagic proteolysis of dicer and enhances tumor metastasis

Lai, H. H., Li, J. N., Wang, M. Y., Huang, H. Y., Croce, C. M., Sun, H. L., Lyu, Y. J., Kang, J. W., Chiu, C. F., Hung, M. C., Suzuki, H. I. & Chen, P. S., 2018 Feb 1, In : Journal of Clinical Investigation. 128, 2, p. 625-643 19 p.

Research output: Contribution to journalArticle

Neoplasm Metastasis
2 Citations (Scopus)

Role of Dicer in regulating oxaliplatin resistance of colon cancer cells

Lai, H. H., Lin, L. J., Hung, L. Y. & Chen, P. S., 2018 Nov 17, In : Biochemical and Biophysical Research Communications. 506, 1, p. 87-93 7 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Colorectal Neoplasms
Ubiquitin-Protein Ligases
3 Citations (Scopus)

A novel application of E1A in combination therapy with EGFR- TKI treatment in breast cancer

Su, C. M., Chang, T. Y., Hsu, H. P., Lai, H. H., Li, J. N., Lyu, Y. J., Kuo, K. T., Huang, M. T., Su, J. L. & Chen, P. S., 2016 Jan 1, In : Oncotarget. 7, 39, p. 63924-63936 13 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Breast Neoplasms
Genetic Therapy
Protein-Tyrosine Kinases
16 Citations (Scopus)

Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects

Chang, Y. W., Su, C. M., Su, Y. H., Ho, Y. S., Lai, H. H., Chen, H. A., Kuo, M. L., Hung, W. C., Chen, Y. W., Wu, C. H., Chen, P. S. & Su, J. L., 2014, In : Oncotarget. 5, 11, p. 3823-3835 13 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor-3
Vascular Endothelial Growth Factor C